News & Analysis as of

Supply Chain Regulatory Requirements Environmental Protection Agency (EPA)

Bergeson & Campbell, P.C.

DOD Publishes 2025 Update on Critical PFAS Uses, Recommends Risk-Based Approach to Defining PFAS

The U.S. Department of Defense (DOD) has published a July 2025 report entitled Update on Critical Per- and Polyfluoroalkyl Substance Uses. House Report 118-121, which accompanied the 2024 DOD appropriations bill (H.R. 4365),...more

Eversheds Sutherland (US) LLP

Global Supply Chain Horizons - July 2025

Welcome to the latest edition of our quarterly global supply chain horizons providing you with a update on the key developments from around the world. Cross-Border - China and the US trade deal - On June 27, the PRC...more

Pillsbury Winthrop Shaw Pittman LLP

Plasticizer PIP (3:1) Ban Is Still a Year Away, but Affected Companies Should Act Today

After October 31, 2026, the distribution in commerce of articles containing PIP (3:1) will be prohibited. Affected companies must phase out the production of PIP (3:1) articles and sell or otherwise remove current inventory....more

Bergeson & Campbell, P.C.

Chemical and Material Risk Management Program TSCA Market Analysis — A Conversation with Patricia Underwood, Ph.D., DABT, MBA and...

This week, I discuss with Patricia Underwood, Ph.D., DABT, MBA, Chief Toxicologist, Principal Director – Chemical and Material Risk Management, Office of the Assistant Secretary of Defense, Department of Defense, and my...more

Benesch

A Primer on U.S. Non-Continuous Domestic Trade

Benesch on

The U.S. inland waterway system is a critical and underutilized component of the domestic supply chain that serves intrastate commerce and non-contiguous markets originating in or destined for Alaska, Hawaii, and U.S....more

King & Spalding

New Executive Order Promotes Domestic Production of Critical Medicines

King & Spalding on

On May 5, 2025, President Donald J. Trump issued Executive Order (“EO”) 14293 entitled Regulatory Relief to Promote Domestic Production of Critical Medicines. The EO directs the U.S. Food and Drug Administration (“FDA”), U.S....more

Akin Gump Strauss Hauer & Feld LLP

The Trump Administration Seeks to Spur Domestic Drug Manufacturing with Regulatory Relief EO

On May 5, President Trump issued an Executive Order (EO) titled “Regulatory Relief to Promote Domestic Production of Critical Medicines,” with the stated purpose of eliminating “regulatory barriers to the domestic production...more

Hogan Lovells

PRODUCT | PFAS and product law: Navigating regulatory and legal risks

Hogan Lovells on

Regulation and litigation surrounding per- and polyfluoroalkyl substances (PFAS) – a class of organic chemicals used in a variety of industrial and consumer products – is on the rise and evolving day-by-day. And the PFAS...more

DLA Piper

Horizon - ESG Regulatory News and Trends, March 2025

DLA Piper on

SEC withdraws defense of US climate disclosure rules; Uyeda speaks on ESG and materiality. On March 27, 2025, the Securities and Exchange Commission (SEC) notified the US Court of Appeals for the Eighth Circuit that the SEC...more

BCLP

HFC Regulation: Navigating Impacts to a Fast-Growing “Climate Control” Industry

BCLP on

Climate control technology is increasingly a focal part of modern society’s expectation to have sophisticated supply chains, particularly relating to perishable items such as pharmaceuticals, raw products, and food. ...more

Foley & Lardner LLP

Foley Automotive Update - December 2025 - 2

Foley & Lardner LLP on

Foley & Lardner announced the 2024 installment of its Auto Trends series—A Year in Review: Updates, Trends and the Road Ahead. This series delves deep into the transformative forces shaping the automotive world by providing...more

DLA Piper

Horizon - ESG Regulatory News and Trends

DLA Piper on

Welcome to Horizon, DLA Piper’s regular bulletin reporting on late-breaking legislative and policy developments in ESG. Our aim is to scan the litigation, enforcement, and regulatory horizon to help inform business decisions....more

12 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide